Ask AI
ProCE Banner Activity

Crossroads: The Intersection of Comorbidities and HIV Care

Conference Coverage
Clinical Thought

Nearly half of all Australian people living with HIV are older than 50 years of age, and AIDS-related mortality is no longer the cause of death among this population, making management of HIV-related comorbidities a top priority among Australian healthcare professionals. Read on to learn which abstracts presented at CROI 2026 are most relevant to the concerns of this region. 

Released: March 16, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Disclosure

Primary Author

Sharon R. Lewin, AO, FRACP, PhD: consultant/advisor/speaker: AbbVie, Gilead, Immunocore, Merck.